Bugan, I. Et Al. 2019. Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate. PROSTATE CANCER AND PROSTATIC DISEASES , vol.22, no.4 , 569-579.

Bugan, I., Kucuk, S., Karagoz, Z., FRASER, S. P., KAYA, H., DODSON, A., ... FOSTER, C. S.(2019). Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate. PROSTATE CANCER AND PROSTATIC DISEASES , vol.22, no.4, 569-579.

Bugan, İlknur Et Al. "Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate," PROSTATE CANCER AND PROSTATIC DISEASES , vol.22, no.4, 569-579, 2019

Bugan, İlknur B. Et Al. "Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate." PROSTATE CANCER AND PROSTATIC DISEASES , vol.22, no.4, pp.569-579, 2019

Bugan, I. Et Al. (2019) . "Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate." PROSTATE CANCER AND PROSTATIC DISEASES , vol.22, no.4, pp.569-579.

@article{article, author={İlknur BUGAN GÜL Et Al. }, title={Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate}, journal={PROSTATE CANCER AND PROSTATIC DISEASES}, year=2019, pages={569-579} }